4LG

METHYL (6-{[(2R)-1-(4-{3-[(2-METHOXYBENZYL)OXY]PROPOXY}PHENYL)-6-OXOPIPERAZIN-2-YL]METHOXY}-1H-INDOL-1-YL)ACETATE

Created:	2006-02-27
Last modified:	2011-06-04

Find Related PDB Entry
1 entries where 4LG is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	80
Chiral Atom Count	1
Bond Count	84
Aromatic Bond Count	22

2D diagram of 4LG

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	METHYL (6-{[(2R)-1-(4-{3-[(2-METHOXYBENZYL)OXY]PROPOXY}PHENYL)-6-OXOPIPERAZIN-2-YL]METHOXY}-1H-INDOL-1-YL)ACETATE
Systematic Name (OpenEye OEToolkits)	methyl 2-[6-[[(2R)-1-[4-[3-[(2-methoxyphenyl)methoxy]propoxy]phenyl]-6-oxo-piperazin-2-yl]methoxy]indol-1-yl]ethanoate
Formula	C₃₃ H₃₇ N₃ O₇
Molecular Weight	587.663
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=C(OC)Cn5ccc4ccc(OCC1N(C(=O)CNC1)c3ccc(OCCCOCc2ccccc2OC)cc3)cc45
SMILES	CACTVS	3.341	COC(=O)Cn1ccc2ccc(OC[CH]3CNCC(=O)N3c4ccc(OCCCOCc5ccccc5OC)cc4)cc12
SMILES	OpenEye OEToolkits	1.5.0	COc1ccccc1COCCCOc2ccc(cc2)N3C(CNCC3=O)COc4ccc5ccn(c5c4)CC(=O)OC
Canonical SMILES	CACTVS	3.341	COC(=O)Cn1ccc2ccc(OC[C@H]3CNCC(=O)N3c4ccc(OCCCOCc5ccccc5OC)cc4)cc12
Canonical SMILES	OpenEye OEToolkits	1.5.0	COc1ccccc1COCCCOc2ccc(cc2)N3[C@H](CNCC3=O)COc4ccc5ccn(c5c4)CC(=O)OC
InChI	InChI	1.03	InChI=1S/C33H37N3O7/c1-39-31-7-4-3-6-25(31)22-41-16-5-17-42-28-12-9-26(10-13-28)36-27(19-34-20-32(36)37)23-43-29-11-8-24-14-15-35(30(24)18-29)21-33(38)40-2/h3-4,6-15,18,27,34H,5,16-17,19-23H2,1-2H3/t27-/m1/s1
InChIKey	InChI	1.03	KWJWTGNGIVRJJK-HHHXNRCGSA-N

Related Resource References

Resource Name	Reference
PubChem	6914635

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.